ALPHARMA INC
10-Q/A, EX-27, 2000-12-04
PHARMACEUTICAL PREPARATIONS
Previous: ALPHARMA INC, 10-Q/A, 2000-12-04
Next: ALPHARMA INC, 10-Q/A, 2000-12-04



<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                          11,266
<SECURITIES>                                         0
<RECEIVABLES>                                  145,025
<ALLOWANCES>                                         0
<INVENTORY>                                    140,923
<CURRENT-ASSETS>                               309,440
<PP&E>                                         405,335
<DEPRECIATION>                                 167,641
<TOTAL-ASSETS>                                 874,963
<CURRENT-LIABILITIES>                          135,336
<BONDS>                                        192,850
                                0
                                          0
<COMMON>                                         5,540
<OTHER-SE>                                     264,395
<TOTAL-LIABILITY-AND-EQUITY>                   874,963
<SALES>                                        155,949
<TOTAL-REVENUES>                               155,949
<CGS>                                           87,941
<TOTAL-COSTS>                                   87,941
<OTHER-EXPENSES>                                50,071
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,466
<INCOME-PRETAX>                                 11,414
<INCOME-TAX>                                     4,216
<INCOME-CONTINUING>                              7,198
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     7,198
<EPS-BASIC>                                        .26
<EPS-DILUTED>                                      .26


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission